Healthlinx said this week that CEO Nick Gatsios will resign as of June 30, 2012.

Gatsios was a founding director of the company when it launched in 2002 and has been its CEO since it went public on the Australian Stock Exchange in 2006. He is extending his contracted notice period by two months in order “to complete current projects of strategic importance,” the company said.

No reason was given for his departure.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.